Global Direct-Fed Microbials Market Grows Steadily at a CAGR of 7.3%

Introduction

Directly-fed microorganisms, sometimes known as probiotics, are beneficial bacteria that enhance gut health. Adding these probiotics to an animal's diet enhances its development and growth. In addition, they fortify animals' immune systems, preventing the development of hazardous organisms in the stomach. Directly fed-microorganisms have altered intestinal bacterial populations, improved disease resistance, decreased pathogen shedding when challenged orally, raised intestinal immunity, reduced disease symptoms, and improved human and animal health. Probiotic bacteria are replacing antibiotics to improve the health and production of agricultural animals.

Market Dynamics

High Need for Probiotics to Save Cost Drives the Global Market

Numerous microbial species in the animal stomach improve energy absorption, transport, conversion, and storage. The gut microbiota influences the energy efficiency of the host animal. The diet of ruminating mammals consists of easily digestible complex carbohydrates. Hence, feed efficiency diminishes, and animals require more feed for nutrition. Therefore, the addition of probiotics to ruminant diets increases fiber digestion. In the animal stomach, probiotics increase cellulolysis and the creation of microbial proteins. Using probiotic microbes aids in degrading complex feed molecules and converting them to simpler chemicals. Animals may rapidly metabolize these molecules to obtain all nutrients from their meal. Thus, animals can absorb more nutrients from less animal feed.

Rising Concerns Regarding the Use of Antibiotics in Animals Creates Tremendous Opportunities

Antibiotics are utilized more commonly for animal production than for human treatment. For instance, about 80 percent of antibiotics are used in agriculture. Most organisms are capable of mutation and environmental adaptation. Antibiotics cannot be entirely assimilated by animals; hence, about 70% of these antibiotics are excreted in their excrement. These antibiotic residues could be transmitted to humans via milk and meat consumption. These antimicrobial-resistant microorganisms can negatively impact human health and cause diseases. The majority of regulatory authorities, including the World Health Organization (WHO), the Food and Agricultural Organization (FAO), and the World Organization for Animal Health, support limiting the use of antibiotics as growth promoters in animal agriculture. As direct-fed microbes are a viable alternative to antibiotics, a ban on antibiotics is anticipated to present enormous prospects for the direct-fed microbial sector.

Regional Analysis

North America is the most significant shareholder in the global direct-fed microbials market and is projected to expand at a CAGR of 7.3% during the forecast period. Historically, antibiotics were employed in animal production as growth enhancers. However, due to the potential for the development of antibiotic-resistant organisms, the use of antibiotics as growth promoters has been prohibited in various regions of North America. A greater understanding of the advantages of probiotic microbial strains has boosted the need for direct-fed microbial in animal agriculture. In addition, a boost in research and development to develop superior strains to enhance the efficiency of animal production has greatly contributed to the expansion of the industry. The United States dominated the direct-fed microbial market in North America, a trend that is predicted to continue over the forecast period. This is attributable to the ban on antibiotics in this region, which has led to increased use of direct-fed microbes in animal feed.

Europe is anticipated to grow at a CAGR of 6.7% over the forecast period. In recent years, Europe's growth can be ascribed to the growing use of direct-fed microbes in animal feed. Growing consumer awareness of the detrimental effects of antibiotics in animal feed is anticipated to stimulate market growth in this sector. Europe restricted the use of antibiotics in 2006. Hence, the direct-fed microbial market in Europe has experienced tremendous growth, which has supported market expansion. However, the European market is mature; therefore, market growth will decelerate throughout the projection period. In addition, the European region has reached its maximum population and is anticipated to drop in the following years. Also, the low fertility rate in this region is expected to lead to a population decline. Europe's population is projected to decline from 735.4 million in 2010 to 7068 million in 2050. Therefore, the proliferation of direct-fed microorganisms in Europe is anticipated to be slow.

Key Highlights

• The global direct-fed microbials market was valued at USD 1,299.14 million in 2022. It is estimated to reach USD 2,449.82 million by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031).
• Based on product type, the global direct-fed microbials market is divided into lactic acid bacteria, Bacillus, and other organisms. The lactic acid bacteria segment is responsible for the largest market share and is estimated to grow at a CAGR of 7.5% over the forecast period.
• Based on livestock, the global direct-fed microbials market is segmented into swine, ruminants, poultry, aquatic animals, and other livestock animals. The swine segment owns the highest market share and is estimated to grow at a CAGR of 8.5% during the forecast period.
• North America is the most significant shareholder in the global direct-fed microbials market and is projected to expand at a CAGR of 7.3% during the forecast period.

Competitive Players

1. Archer-Daniels-Midland Company
2. Biomin Holding GmbH
3. Koninklijke DSM N.V BIO-VET
4. Chr. Hansen A/S
5. Novozymes
6. Kemin Industries Inc
7. I. DU Pont De Nemours and Co
8. and Novus International Inc.

Recent Developments

• October 2022- Zinpro Corporation, the world's leading designer and supplier of high-performance organic trace minerals and animal nutrition solutions, announced the launch of its newest innovation: Zinpro IsoFerm. Zinpro IsoFerm is a vital nutrient that drives rumen activity by directly nourishing fiber-digesting microbes.

• January 2023- Danisco Animal Nutrition & Health, a division of IFF, announced that Enviva® PRO and Syncra® SWI had obtained approval from the Canadian Food Inspection Agency (CFIA). Introducing the newly authorized feed solutions into poultry and swine diets will provide Canadian producers with more consistent animal performance throughout the year.

 

Segmentation

1. By Product Type
   1. Lactic Acid Bacteria
   2. Bacillus
   3. Others
2. By Livestock
   1. Swine
   2. Ruminants
   3. Poultry
   4. Aquatic Animals
   5. Others